CERO THERAPEUTICS HOLDINGS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$308.09 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2022-05-13
- CERO THERAPEUTICS HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2022-03-31 was -$308.09K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 4 month | Cash and Cash Equivalents, Period Increase (Decrease) 7 month |
|---|---|---|---|
| 2022-03-31 | -$308.09K 10-Q · filed 2022-05-13 | ||
| 2021-12-31 | $1.10M 10-K · filed 2022-03-24 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |